Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022

Clin Infect Dis. 2023 Jul 26;77(2):298-302. doi: 10.1093/cid/ciad145.

Abstract

We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.

Keywords: asymptomatic; mpox; pharyngeal swab; rectal swab.

MeSH terms

  • District of Columbia
  • Exanthema* / etiology
  • Humans
  • Mpox (monkeypox)*
  • Vaccines, Attenuated
  • Virus Diseases*

Substances

  • smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
  • Vaccines, Attenuated